SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Global Arena Holding, Inc. – ‘10-Q’ for 9/30/20 – ‘EX-31’

On:  Monday, 11/16/20, at 2:57pm ET   ·   For:  9/30/20   ·   Accession #:  1014897-20-86   ·   File #:  0-49819

Previous ‘10-Q’:  ‘10-Q’ on 10/1/20 for 6/30/20   ·   Next:  ‘10-Q’ on 5/11/21 for 3/31/21   ·   Latest:  ‘10-Q/A’ on 4/4/24 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/16/20  Global Arena Holding, Inc.        10-Q        9/30/20   56:3.9M                                   Walker Jody M/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Global Arena Form 10-Q 09-30-20                     HTML    250K 
 2: EX-31       Certification -- §302 - SOA'02                      HTML     19K 
 3: EX-32       Certification -- §906 - SOA'02                      HTML     17K 
10: R1          Document and Entity Information                     HTML     65K 
11: R2          Condensed Consolidated Balance Sheets               HTML     83K 
12: R3          Condensed Consolidated Balance Sheets               HTML     37K 
                (Parenthetical)                                                  
13: R4          Condensed Consolidated Statements of Operations     HTML     94K 
                (Unaudited)                                                      
14: R5          Condensed Consolidated Statements of Stockholders'  HTML     91K 
                Deficit                                                          
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     77K 
                (Unaudited)                                                      
16: R7          Organization                                        HTML     34K 
17: R8          Summary of Significant Accounting Policies          HTML     94K 
18: R9          Investment                                          HTML     20K 
19: R10         Acquisition Deposits                                HTML     24K 
20: R11         Accrued Expenses                                    HTML     31K 
21: R12         Promissory Notes Payable                            HTML     19K 
22: R13         Convertible Promissory Notes Payable                HTML     51K 
23: R14         Derivative Financial Instruments                    HTML     40K 
24: R15         Stockholders' Deficit                               HTML     98K 
25: R16         Commitments and Contingencies                       HTML     22K 
26: R17         Agreements                                          HTML     29K 
27: R18         Subsequent Events                                   HTML     20K 
28: R19         Summary of Significant Accounting Policies          HTML    127K 
                (Policies)                                                       
29: R20         Summary of Significant Accounting Policies          HTML     70K 
                (Tables)                                                         
30: R21         Accrued Expenses (Tables)                           HTML     30K 
31: R22         Convertible Promissory Notes Payable (Tables)       HTML     51K 
32: R23         Derivative Financial Instruments (Tables)           HTML     42K 
33: R24         Stockholders' Deficit (Tables)                      HTML     93K 
34: R25         Organization (Narrative) (Details)                  HTML     66K 
35: R26         Summary of Significant Accounting Policies          HTML     27K 
                (Schedule Of Antidilutive Securities Excluded From               
                Earnings) (Details)                                              
36: R27         Summary of Significant Accounting Policies          HTML     31K 
                (Schedule Of Fair Value Of Assets And Liabilities)               
                (Details)                                                        
37: R28         Investment (Narrative) (Details)                    HTML     38K 
38: R29         Acquisition Deposits (Narrative) (Details)          HTML     67K 
39: R30         Accrued Expenses (Schedule of Accrued Liabilities)  HTML     26K 
                (Details)                                                        
40: R31         Promissory Notes Payable (Narrative) (Details)      HTML     29K 
41: R32         Convertible Promissory Notes Payable (Schedule Of   HTML     40K 
                Convertible Promissory Notes Payable) (Details)                  
42: R33         Convertible Promissory Notes Payable (Schedule Of   HTML     54K 
                Convertible Promissory Notes Payable) (Details)                  
                (Parenthetical)                                                  
43: R34         Convertible Promissory Notes Payable (Schedule Of   HTML     34K 
                Rollfoward Of Convertible Promissory Notes                       
                Payable) (Details)                                               
44: R35         Derivative Financial Instruments (Valuation         HTML     33K 
                Techniques Used In Fair Value Of Derivative                      
                Liability) (Details)                                             
45: R36         Derivative Financial Instruments (Schedule Of       HTML     24K 
                Changes In Fair Value Of Financial Derivatives)                  
                (Details)                                                        
46: R37         Stockholders' Deficit (Summary Of Stock Option      HTML     51K 
                Activity) (Details)                                              
47: R38         Stockholders' Deficit (Summary Of Warrant           HTML     57K 
                Activity) (Details)                                              
48: R39         Stockholders' Deficit (Series B Preferred Stock)    HTML     42K 
                (Narrative) (Details)                                            
49: R40         Stockholders' Deficit (Common Stock) (Narrative)    HTML     36K 
                (Details)                                                        
50: R41         Stockholders' Deficit (Warrant Activity)            HTML     38K 
                (Narrative) (Details)                                            
51: R42         Commitments and Contingencies (Narrative)           HTML     31K 
                (Details)                                                        
52: R43         Agreements (Narrative) (Details)                    HTML     62K 
53: R44         Subsequent Events (Narrative) (Details)             HTML     27K 
55: XML         IDEA XML File -- Filing Summary                      XML    102K 
54: EXCEL       IDEA Workbook of Financial Reports                  XLSX     64K 
 9: EX-101.INS  Extracted XBRL Instance Document -- gahc-20200930    XML   1.16M 
 5: EX-101.CAL  XBRL Calculations -- gahc-20200930_cal               XML     80K 
 6: EX-101.DEF  XBRL Taxonomy Extension Definitive Linkbase          XML    434K 
                Document -- gahc-20200930_def                                    
 7: EX-101.LAB  XBRL Labels -- gahc-20200930_lab                     XML   1.11M 
 8: EX-101.PRE  XBRL Presentations -- gahc-20200930_pre              XML    694K 
 4: EX-101.SCH  XBRL Schema -- gahc-20200930                         XSD    147K 
56: ZIP         XBRL Zipped Folder -- 0001014897-20-000086-xbrl      Zip    122K 


‘EX-31’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <! 
  Converted by EDGARwiz  
 <>   <> 

302 CERTIFICATION


I, John Matthews, certify that:


   1. I have reviewed this quarterly report on Form 10-Q of Global Arena Holding Inc.;


   2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


   3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


   4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


     b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


     c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report, our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


     d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and


   5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):


     a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


     b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.


Date: November 16, 2020


/s/John Matthews

John Matthews

Chief Executive Officer

Chief Financial Officer




 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/16/20
For Period end:9/30/2010-Q,  NT 10-Q
 List all Filings 
Top
Filing Submission 0001014897-20-000086   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 6:59:04.1pm ET